首页 > 最新文献

Journal of Ayurveda Case Reports最新文献

英文 中文
Standardized terminologies: A powerful tool for systematic reviews in Ayurveda 标准化术语:阿育吠陀学系统审查的有力工具
Pub Date : 2023-07-01 DOI: 10.4103/jacr.jacr_205_23
T. Nesari
{"title":"Standardized terminologies: A powerful tool for systematic reviews in Ayurveda","authors":"T. Nesari","doi":"10.4103/jacr.jacr_205_23","DOIUrl":"https://doi.org/10.4103/jacr.jacr_205_23","url":null,"abstract":"","PeriodicalId":239185,"journal":{"name":"Journal of Ayurveda Case Reports","volume":"16 1","pages":"89 - 91"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139364575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating technology and Ayurveda: An experience of dilemmas in a postgraduate research scholar leading to pioneering research 技术与阿育吠陀的结合:研究生研究学者在开拓性研究中的两难经历
Pub Date : 2023-07-01 DOI: 10.4103/jacr.jacr_186_23
Pooja Huilgol
{"title":"Integrating technology and Ayurveda: An experience of dilemmas in a postgraduate research scholar leading to pioneering research","authors":"Pooja Huilgol","doi":"10.4103/jacr.jacr_186_23","DOIUrl":"https://doi.org/10.4103/jacr.jacr_186_23","url":null,"abstract":"","PeriodicalId":239185,"journal":{"name":"Journal of Ayurveda Case Reports","volume":"4 1","pages":"143 - 144"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139364908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An approach of Ayurveda clinical diagnosis in managing acute Pakshavadha (~hemiplegia): A case report 用阿育吠陀临床诊断法治疗急性帕克沙瓦达(~半身不遂):病例报告
Pub Date : 2023-07-01 DOI: 10.4103/jacr.jacr_107_22
Arundhati Mukhedkar, Anup Thakar, Rahul Gandhi
The case presented is to exemplify the use of Ayurveda diagnostic techniques in treating diseases. Among the diagnostic tools, Upashaya-Anupashaya (~understanding of aggravating and relieving factors) is useful during unclear pathology and symptomatology. Upashaya is the betterment, and Anupashaya is the aggravation of disease by medication, diet, and lifestyle. The case presented here is of a 60-year-old male with sudden weakness of the left upper and lower extremities, with no other symptoms and significant previous medical history. The provisional diagnosis was Pakshavadha (~hemiplegia) and treated through Brimhana (~nourishing therapy), which led to the aggravation of the disease condition. Anupashaya by Brimhana treatment confirmed the diagnosis to Kaphavrita Vata (~occlusion of Vata by Kapha dosha) and was treated with Rukshana (~dryness inducing therapies), Pachana (~enhancing digestion) with significant relief in symptoms within four days, with no recurrence. The significance of Upashaya-Anupashaya in the confirmation of disease and treatment is highlighted in this case.
本病例是阿育吠陀诊断技术用于治疗疾病的范例。在诊断工具中,Upashaya-Anupashaya(~对加重和缓解因素的理解)在不清楚病理和症状时非常有用。Upashaya 是改善,Anupashaya 是通过药物、饮食和生活方式加重疾病。本文介绍的病例是一名 60 岁男性,突发左上下肢无力,无其他症状,既往病史丰富。临时诊断为帕克沙瓦达(Pakshavadha)(~半身不遂),并通过布里姆哈纳(Brimhana)(~营养疗法)进行治疗,结果导致病情加重。通过 Brimhana 疗法进行的 Anupashaya 诊断确认为 Kaphavrita Vata(Kapha dosha 阻塞 Vata),并采用 Rukshana(干燥诱导疗法)和 Pachana(促进消化疗法)进行治疗,四天内症状明显缓解,且没有复发。在这个病例中,Upashaya-Anupashaya 在确认疾病和治疗方面的重要性得到了突出体现。
{"title":"An approach of Ayurveda clinical diagnosis in managing acute Pakshavadha (~hemiplegia): A case report","authors":"Arundhati Mukhedkar, Anup Thakar, Rahul Gandhi","doi":"10.4103/jacr.jacr_107_22","DOIUrl":"https://doi.org/10.4103/jacr.jacr_107_22","url":null,"abstract":"The case presented is to exemplify the use of Ayurveda diagnostic techniques in treating diseases. Among the diagnostic tools, Upashaya-Anupashaya (~understanding of aggravating and relieving factors) is useful during unclear pathology and symptomatology. Upashaya is the betterment, and Anupashaya is the aggravation of disease by medication, diet, and lifestyle. The case presented here is of a 60-year-old male with sudden weakness of the left upper and lower extremities, with no other symptoms and significant previous medical history. The provisional diagnosis was Pakshavadha (~hemiplegia) and treated through Brimhana (~nourishing therapy), which led to the aggravation of the disease condition. Anupashaya by Brimhana treatment confirmed the diagnosis to Kaphavrita Vata (~occlusion of Vata by Kapha dosha) and was treated with Rukshana (~dryness inducing therapies), Pachana (~enhancing digestion) with significant relief in symptoms within four days, with no recurrence. The significance of Upashaya-Anupashaya in the confirmation of disease and treatment is highlighted in this case.","PeriodicalId":239185,"journal":{"name":"Journal of Ayurveda Case Reports","volume":"1 1","pages":"98 - 102"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139365401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Shodhana karma, Lekhana karma and Raktamokshana in the management of Luta vishajanya vrana: A case report Shodhana karma、Lekhana karma 和 Raktamokshana 在治疗 Luta vishajanya vrana 中的效果:病例报告
Pub Date : 2023-07-01 DOI: 10.4103/jacr.jacr_80_22
Anisha Ashraf, B. Gopikrishna, Prasanna Rao
Spider bites are commonly reported from many parts of the world. In classical literature, spider envenomation is coined as Luta visha (~spider bite poisoning). A 20-year-old male patient approached to outpatient department with the chief complaint of a wound over the calf muscle region of the right lower limb associated with watery discharge, itching, pain, and burning sensation for the past six months. There was a mild rise in temperature. On evaluation, the symptoms were identified to be spider-bite poisoning. The patient was given classical Ayurveda therapeutic measures, which include Virechana (~therapeutic purgation), followed by Lekhana karma (~therapeutic scrapping) over the site of the bite and Jalaukavacharana (~bloodletting using leech) for five days. At the time of discharge, Bilvadi gutika (860 mg) twice daily for one month was advised. A remarkable improvement was observed in the condition of the patient within 14 days of treatment. The treatment approach, including Virechana, Lekhana karma, and Raktamokshana, gave significant results with complete healing of Luta vishajanya vrana (~spider poison-induced ulcer) within the span of six months. After treatment, no recurrence of symptoms was observed when followed the patient up to two months.
世界上许多地方都有蜘蛛咬伤的报道。在古典文献中,蜘蛛咬伤被称为 "蜘蛛咬伤中毒"(Luta visha)。门诊部接诊了一名 20 岁的男性患者,主诉是右下肢小腿肌肉区域有伤口,伴有水样分泌物、瘙痒、疼痛和烧灼感,已持续六个月。体温轻度升高。经评估,这些症状被确认为蜘蛛咬伤中毒。患者接受了经典的阿育吠陀治疗措施,包括 Virechana(治疗性清洗),然后在咬伤部位进行 Lekhana karma(治疗性刮伤)和 Jalaukavacharana(使用水蛭放血),连续五天。出院时,建议使用 Bilvadi gutika(860 毫克),每天两次,持续一个月。治疗 14 天后,患者的病情明显好转。包括 Virechana、Lekhana karma 和 Raktamokshana 在内的治疗方法取得了显著效果,Luta vishajanya vrana(〜蜘蛛毒引起的溃疡)在六个月内完全愈合。治疗后,对患者进行了长达两个月的跟踪观察,没有发现症状复发。
{"title":"Effect of Shodhana karma, Lekhana karma and Raktamokshana in the management of Luta vishajanya vrana: A case report","authors":"Anisha Ashraf, B. Gopikrishna, Prasanna Rao","doi":"10.4103/jacr.jacr_80_22","DOIUrl":"https://doi.org/10.4103/jacr.jacr_80_22","url":null,"abstract":"Spider bites are commonly reported from many parts of the world. In classical literature, spider envenomation is coined as Luta visha (~spider bite poisoning). A 20-year-old male patient approached to outpatient department with the chief complaint of a wound over the calf muscle region of the right lower limb associated with watery discharge, itching, pain, and burning sensation for the past six months. There was a mild rise in temperature. On evaluation, the symptoms were identified to be spider-bite poisoning. The patient was given classical Ayurveda therapeutic measures, which include Virechana (~therapeutic purgation), followed by Lekhana karma (~therapeutic scrapping) over the site of the bite and Jalaukavacharana (~bloodletting using leech) for five days. At the time of discharge, Bilvadi gutika (860 mg) twice daily for one month was advised. A remarkable improvement was observed in the condition of the patient within 14 days of treatment. The treatment approach, including Virechana, Lekhana karma, and Raktamokshana, gave significant results with complete healing of Luta vishajanya vrana (~spider poison-induced ulcer) within the span of six months. After treatment, no recurrence of symptoms was observed when followed the patient up to two months.","PeriodicalId":239185,"journal":{"name":"Journal of Ayurveda Case Reports","volume":"9 1","pages":"113 - 118"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139364695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of chemotherapy adversity through Ayurveda: An experience 通过阿育吠陀治疗化疗逆境:经验之谈
Pub Date : 2023-07-01 DOI: 10.4103/jacr.jacr_148_22
M. Deogade
Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. Chemotherapy is the largely accepted treatment protocol for cancer, but it comes with an increased risk of infections and side effects. Ayurveda can be a promising adjunct therapy to minimize the adverse effects of chemoradiotherapy. A 65-year-old female who was a known case of double-vessel block suddenly developed severe abdominal pain and was treated symptomatically by a general physician. Her weight loss was consistent with multiple episodes of abdominal pain for a year after which she was diagnosed to have moderately differentiated adenocarcinoma of the cecum. The patient was managed with exploratory laparotomy (with right hemicolectomy with ileal transverse colon end-to-end anastomosis). The histopathology study reported it as a Modified Astler–Coller stage C2. Consequently, six cycles of Folfox (chemotherapy) were advised by the oncologist. Before starting the chemotherapy, Ayurveda treatment was started to combat the expected side effects of chemotherapy. The treatment protocol included Dhanyaka phanta, Suvarnamalini vasanta, Madiphala rasayana, and Guduchyadi ksheerapaka. The patient had no additional complaints during the chemotherapy and all the hematological parameters were within normal limits. The patient reported weight gain after completion of the chemotherapy. Expected side effects (hair loss, mouth sores, anorexia, diarrhea, and vomiting) were not reported during the treatment. Known side effects of chemotherapy like infection, easy bruising, bleeding, or fatigue were also not reported; therefore, the present study concludes that the side effects of chemotherapy may be controlled by Ayurveda adjunct therapy.
癌症是导致全球死亡的主要原因,2020 年将有近 1000 万人死于癌症。化疗是公认的癌症治疗方案,但同时也增加了感染和副作用的风险。阿育吠陀可以作为一种很有前景的辅助疗法,将化学放疗的不良反应降至最低。一名已知患有双血管阻塞的 65 岁女性突然出现剧烈腹痛,全科医师对其进行了对症治疗。她的体重减轻与一年来多次发作的腹痛相吻合,之后她被诊断出患有中度分化的盲肠腺癌。患者接受了剖腹探查术(右半结肠切除术,回肠横结肠端端吻合术)。组织病理学研究报告称其为改良 Astler-Coller C2 期。因此,肿瘤专家建议患者接受六个周期的 Folfox(化疗)。在开始化疗之前,患者接受了阿育吠陀治疗,以消除化疗的预期副作用。治疗方案包括 Dhanyaka phanta、Suvarnamalini vasanta、Madiphala rasayana 和 Guduchyadi ksheerapaka。化疗期间,患者没有其他不适症状,所有血液指标均在正常范围内。化疗结束后,患者的体重有所增加。在治疗期间,患者没有出现预期的副作用(脱发、口腔溃疡、厌食、腹泻和呕吐)。感染、易瘀伤、出血或疲劳等已知的化疗副作用也未见报道;因此,本研究得出结论,阿育吠陀辅助疗法可控制化疗副作用。
{"title":"Management of chemotherapy adversity through Ayurveda: An experience","authors":"M. Deogade","doi":"10.4103/jacr.jacr_148_22","DOIUrl":"https://doi.org/10.4103/jacr.jacr_148_22","url":null,"abstract":"Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. Chemotherapy is the largely accepted treatment protocol for cancer, but it comes with an increased risk of infections and side effects. Ayurveda can be a promising adjunct therapy to minimize the adverse effects of chemoradiotherapy. A 65-year-old female who was a known case of double-vessel block suddenly developed severe abdominal pain and was treated symptomatically by a general physician. Her weight loss was consistent with multiple episodes of abdominal pain for a year after which she was diagnosed to have moderately differentiated adenocarcinoma of the cecum. The patient was managed with exploratory laparotomy (with right hemicolectomy with ileal transverse colon end-to-end anastomosis). The histopathology study reported it as a Modified Astler–Coller stage C2. Consequently, six cycles of Folfox (chemotherapy) were advised by the oncologist. Before starting the chemotherapy, Ayurveda treatment was started to combat the expected side effects of chemotherapy. The treatment protocol included Dhanyaka phanta, Suvarnamalini vasanta, Madiphala rasayana, and Guduchyadi ksheerapaka. The patient had no additional complaints during the chemotherapy and all the hematological parameters were within normal limits. The patient reported weight gain after completion of the chemotherapy. Expected side effects (hair loss, mouth sores, anorexia, diarrhea, and vomiting) were not reported during the treatment. Known side effects of chemotherapy like infection, easy bruising, bleeding, or fatigue were also not reported; therefore, the present study concludes that the side effects of chemotherapy may be controlled by Ayurveda adjunct therapy.","PeriodicalId":239185,"journal":{"name":"Journal of Ayurveda Case Reports","volume":"58 1","pages":"103 - 107"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139364730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Uttana vatarakta (limited cutaneous systemic sclerosis): An experience through Ayurveda management strategies Uttana vatarakta(局限性皮肤系统硬化症)的管理:通过阿育吠陀管理策略获得的经验
Pub Date : 2023-07-01 DOI: 10.4103/jacr.jacr_46_22
Ekta Sutaria, Devendrasingh Rajput, M. Anagha, Darshna Pandya
Scleroderma (systemic sclerosis) is a group of rare diseases that involve the hardening and tightening of the skin and connective tissues. Diffuse cutaneous scleroderma and Limited Cutaneous Systemic Sclerosis (LcSSC) are the two major classifications of it. LcSSc usually affects the skin and further spreads to muscles and joints, but in about 10% cases, involvement of internal organs like gastrointestinal tract and manifestations like pulmonary hypertension is seen even after 10–15 years. The prevalence of the disease is 17.6/100,000 population. As far as the management of LcSSC in conventional medicine is concerned, other than symptomatic relief; immunosuppressive drugs are given, but long-term use of such medicines suppresses the immunity of the patient and hence the patient may get affected with opportunistic infections and causes severe complications. Hence, some alternatives in this direction are being explored from other systems of medicines for the betterment of patients. The direct description of the disease scleroderma is not available in Ayurvedic literature, but based on its presentation, it can be correlated with different stages of Vatarakta (~rheumatism due to blood tissue). A 20-year-old young male patient with presentation of limited scleroderma managed with Ayurveda therapy by Virechana (~therapeutic purgation) followed by Shamana (~palliative) therapy for one and half months and obtained encouraging results, inferring that Ayurveda therapeutic protocols can be successfully adopted in cases like LcSSC.
硬皮病(系统性硬化症)是一组罕见疾病,涉及皮肤和结缔组织的硬化和紧绷。弥漫性皮肤硬皮病和局限性皮肤系统性硬化症(LcSSC)是它的两种主要分类。局限性皮肤系统硬化症通常影响皮肤,并进一步扩散到肌肉和关节,但约有 10%的病例甚至在 10-15 年后才出现胃肠道等内脏器官受累和肺动脉高压等表现。该病的发病率为 17.6/100,000。就传统医学对 LcSSC 的治疗而言,除了缓解症状外,还给予免疫抑制剂,但长期使用这类药物会抑制患者的免疫力,因此患者可能会受到机会性感染并引起严重的并发症。因此,为了更好地造福患者,我们正在从其他药物系统中探索一些替代方案。阿育吠陀文献中没有关于硬皮病的直接描述,但根据其表现形式,可以将其与 Vatarakta(~血液组织引起的风湿病)的不同阶段联系起来。一名 20 岁的年轻男性患者表现为局限性硬皮病,在接受阿育吠陀疗法治疗一个半月后,接受了 Virechana(治疗性净化)和 Shamana(缓解性)疗法,并取得了令人鼓舞的效果,由此推断阿育吠陀疗法方案可成功用于 LcSSC 等病例。
{"title":"Management of Uttana vatarakta (limited cutaneous systemic sclerosis): An experience through Ayurveda management strategies","authors":"Ekta Sutaria, Devendrasingh Rajput, M. Anagha, Darshna Pandya","doi":"10.4103/jacr.jacr_46_22","DOIUrl":"https://doi.org/10.4103/jacr.jacr_46_22","url":null,"abstract":"Scleroderma (systemic sclerosis) is a group of rare diseases that involve the hardening and tightening of the skin and connective tissues. Diffuse cutaneous scleroderma and Limited Cutaneous Systemic Sclerosis (LcSSC) are the two major classifications of it. LcSSc usually affects the skin and further spreads to muscles and joints, but in about 10% cases, involvement of internal organs like gastrointestinal tract and manifestations like pulmonary hypertension is seen even after 10–15 years. The prevalence of the disease is 17.6/100,000 population. As far as the management of LcSSC in conventional medicine is concerned, other than symptomatic relief; immunosuppressive drugs are given, but long-term use of such medicines suppresses the immunity of the patient and hence the patient may get affected with opportunistic infections and causes severe complications. Hence, some alternatives in this direction are being explored from other systems of medicines for the betterment of patients. The direct description of the disease scleroderma is not available in Ayurvedic literature, but based on its presentation, it can be correlated with different stages of Vatarakta (~rheumatism due to blood tissue). A 20-year-old young male patient with presentation of limited scleroderma managed with Ayurveda therapy by Virechana (~therapeutic purgation) followed by Shamana (~palliative) therapy for one and half months and obtained encouraging results, inferring that Ayurveda therapeutic protocols can be successfully adopted in cases like LcSSC.","PeriodicalId":239185,"journal":{"name":"Journal of Ayurveda Case Reports","volume":"6 1","pages":"125 - 130"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139365551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurvedic management of Vipadika (~palmoplantar psoriasis): A case report 阿育吠陀疗法治疗 Vipadika(~掌跖银屑病):病例报告
Pub Date : 2023-07-01 DOI: 10.4103/jacr.jacr_86_22
Pratibha, Sudipta Rath, Manaswi Surolia
In Ayurveda, skin disorders are included under a broad category of diseases, namely, Kushta. There are 18 types of Kushta described in Ayurveda. Out of which, Vipadika (~cracks in palms and soles) is one. It can be correlated with palmoplantar psoriasis. According to ancient seers of Ayurveda, Pani pada sphutana (~cracks in palms and soles), Tivra vedana (~severe pain), Manda kandu (~mild itching), and Saraga pidika (~redness associated with eruptions) are the symptoms of Vipadika. In the present case report, a 62-year-old male patient complained of dryness and cracking of the left sole with roughness associated with itching on the plantar aspect of the left foot and severe pain during walking for two years. He was taking allopathic treatment for two years but had limited relief. The patient has difficulty in mobility and daily activities. A combination of Shuddha gandhaka, Rasamanikya, and Chopachini churna along with Kaishore guggulu, Raktaprasadaka hima, Panchatikta ghrita, Panchasakara churna, Arogyavardhini vati, and Sarivadyasava as internal medicines and Haridra, Rasamanikya along with Yashtimadhu was prescribed as a local application. The patient was advised to follow Pathya and Apathya (~wholesome and unwholesome diet) during the treatment. Within three months of the treatment, the psoriatic lesions and associated signs and symptoms were healed effectively.
在阿育吠陀中,皮肤病属于疾病的一个大类,即 Kushta。阿育吠陀中描述了 18 种 Kushta。其中,Vipadika(~手掌和脚底的裂缝)就是一种。它可以与掌跖银屑病联系起来。根据古代阿育吠陀先贤的说法,Pani pada sphutana(~手掌和足底的裂纹)、Tivra vedana(~剧烈疼痛)、Manda kandu(~轻微瘙痒)和 Saraga pidika(~与糜烂相关的红斑)是 Vipadika 的症状。在本病例报告中,一名 62 岁的男性患者主诉左脚脚底干燥、开裂、粗糙,伴有瘙痒,行走时剧烈疼痛,已有两年之久。他接受了两年的对抗疗法,但缓解有限。患者行动不便,难以进行日常活动。医生开出了 Shuddha gandhaka、Rasamanikya 和 Chopachini churna 的组合药方,同时还开出了 Kaishore guggulu、Raktaprasadaka hima、Panchatikta ghrita、Panchasakara churna、Arogyavardhini vati 和 Sarivadyasava 作为内服药,以及 Haridra、Rasamanikya 和 Yashtimadhu 作为局部用药。建议患者在治疗期间遵循 Pathya 和 Apathya(~健康和不健康饮食)原则。在治疗的三个月内,银屑病皮损及相关症状和体征得到了有效治愈。
{"title":"Ayurvedic management of Vipadika (~palmoplantar psoriasis): A case report","authors":"Pratibha, Sudipta Rath, Manaswi Surolia","doi":"10.4103/jacr.jacr_86_22","DOIUrl":"https://doi.org/10.4103/jacr.jacr_86_22","url":null,"abstract":"In Ayurveda, skin disorders are included under a broad category of diseases, namely, Kushta. There are 18 types of Kushta described in Ayurveda. Out of which, Vipadika (~cracks in palms and soles) is one. It can be correlated with palmoplantar psoriasis. According to ancient seers of Ayurveda, Pani pada sphutana (~cracks in palms and soles), Tivra vedana (~severe pain), Manda kandu (~mild itching), and Saraga pidika (~redness associated with eruptions) are the symptoms of Vipadika. In the present case report, a 62-year-old male patient complained of dryness and cracking of the left sole with roughness associated with itching on the plantar aspect of the left foot and severe pain during walking for two years. He was taking allopathic treatment for two years but had limited relief. The patient has difficulty in mobility and daily activities. A combination of Shuddha gandhaka, Rasamanikya, and Chopachini churna along with Kaishore guggulu, Raktaprasadaka hima, Panchatikta ghrita, Panchasakara churna, Arogyavardhini vati, and Sarivadyasava as internal medicines and Haridra, Rasamanikya along with Yashtimadhu was prescribed as a local application. The patient was advised to follow Pathya and Apathya (~wholesome and unwholesome diet) during the treatment. Within three months of the treatment, the psoriatic lesions and associated signs and symptoms were healed effectively.","PeriodicalId":239185,"journal":{"name":"Journal of Ayurveda Case Reports","volume":"105 1","pages":"131 - 136"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139365711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adenocarcinoma of the lung treated with add-on Ayurveda treatment: A case report 用阿育吠陀附加疗法治疗肺腺癌:病例报告
Pub Date : 2023-07-01 DOI: 10.4103/jacr.jacr_90_22
Ranjeet Nimbalkar, Sanjay Kolte, Akshay Baheti, Prerna Haritwal, Manasi Nimbalkar
Studies conducted in 2020 predicted that 1,392,179 people in India suffer from cancer. The six most common sites are breast, lung, mouth, cervix, uterus, and tongue. Among these, lung cancers are reported to have the greatest fatality rate. In the present case, a 49-year-old male patient suffering from adenocarcinoma in the upper lobe of the left lung was managed with herbo-mineral Ayurvedic combinations along with conventional treatment. He had a history of right-sided chest pain after facing a fall from stairs. The chest X-ray showed a right-sided rib fracture. However, as an additional accidental finding, a 3-cm mass on the upper lobe of the left lung was also visible, which was found malignant after the detailed investigations. The patient was initially treated with conventional treatment and surgery, followed by chemotherapy. During chemotherapy, he had complaints of pain, numbness of hands and legs, nausea, anorexia, and severe weakness. Hence, concurrent Ayurvedic treatment was also started after the second cycle of chemotherapy (January 27, 2019), and after completing the modern treatment, Ayurveda treatment was continued till May 27, 2023, accounting for five years approximately. The combination therapy module provided complete symptom alleviation and marked improvement in the positron emission tomography scan that showed marked improvement and did not show any new abnormality in subsequent follow-ups. No recurrences were noticed for the last more than four years. The fact that all of the symptoms have alleviated and investigations show no abnormality is suggestive that the add-on Ayurveda treatment in this case of adenocarcinoma has aided the patient with a more than four year disease-free survival along with the good quality of life as determined by Karnofsky score (90/100).
2020 年进行的研究预测,印度将有 1 392 179 人罹患癌症。最常见的六个部位是乳腺癌、肺癌、口腔癌、宫颈癌、子宫癌和舌癌。据报道,其中肺癌的致死率最高。在本病例中,一名 49 岁的男性患者患有左肺上叶腺癌,在接受常规治疗的同时,还接受了草本矿物质阿育吠陀组合疗法。他曾在一次从楼梯上摔下后出现右侧胸痛。胸部 X 光片显示右侧肋骨骨折。然而,作为额外的意外发现,左肺上叶上还可见一个 3 厘米的肿块,经过详细检查后发现是恶性的。患者最初接受了常规治疗和手术,随后接受了化疗。化疗期间,他主诉疼痛、手脚麻木、恶心、厌食和严重虚弱。因此,在第二个化疗周期(2019 年 1 月 27 日)后,阿育吠陀治疗也开始同时进行,在完成现代治疗后,阿育吠陀治疗一直持续到 2023 年 5 月 27 日,约为五年。综合治疗模块使症状得到了完全缓解,正电子发射断层扫描结果也有明显改善,在随后的随访中未发现任何新的异常。在过去的四年多时间里,没有发现任何复发。所有症状均已缓解,检查也未发现异常,这一事实表明,阿育吠陀附加疗法对该腺癌病例的治疗帮助患者获得了四年多的无病生存期,而且根据 Karnofsky 评分(90/100),患者的生活质量也很高。
{"title":"Adenocarcinoma of the lung treated with add-on Ayurveda treatment: A case report","authors":"Ranjeet Nimbalkar, Sanjay Kolte, Akshay Baheti, Prerna Haritwal, Manasi Nimbalkar","doi":"10.4103/jacr.jacr_90_22","DOIUrl":"https://doi.org/10.4103/jacr.jacr_90_22","url":null,"abstract":"Studies conducted in 2020 predicted that 1,392,179 people in India suffer from cancer. The six most common sites are breast, lung, mouth, cervix, uterus, and tongue. Among these, lung cancers are reported to have the greatest fatality rate. In the present case, a 49-year-old male patient suffering from adenocarcinoma in the upper lobe of the left lung was managed with herbo-mineral Ayurvedic combinations along with conventional treatment. He had a history of right-sided chest pain after facing a fall from stairs. The chest X-ray showed a right-sided rib fracture. However, as an additional accidental finding, a 3-cm mass on the upper lobe of the left lung was also visible, which was found malignant after the detailed investigations. The patient was initially treated with conventional treatment and surgery, followed by chemotherapy. During chemotherapy, he had complaints of pain, numbness of hands and legs, nausea, anorexia, and severe weakness. Hence, concurrent Ayurvedic treatment was also started after the second cycle of chemotherapy (January 27, 2019), and after completing the modern treatment, Ayurveda treatment was continued till May 27, 2023, accounting for five years approximately. The combination therapy module provided complete symptom alleviation and marked improvement in the positron emission tomography scan that showed marked improvement and did not show any new abnormality in subsequent follow-ups. No recurrences were noticed for the last more than four years. The fact that all of the symptoms have alleviated and investigations show no abnormality is suggestive that the add-on Ayurveda treatment in this case of adenocarcinoma has aided the patient with a more than four year disease-free survival along with the good quality of life as determined by Karnofsky score (90/100).","PeriodicalId":239185,"journal":{"name":"Journal of Ayurveda Case Reports","volume":"100 1","pages":"92 - 97"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139364447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Amavata with Panchakarma treatment – A case report 用潘查卡玛疗法治疗阿马瓦塔--病例报告
Pub Date : 2023-07-01 DOI: 10.4103/jacr.jacr_69_22
Diksha Kabra, Santosh Bhatted
Rheumatoid Arthritis (RA) is an autoimmune systemic disease, resulting in functional decline, disability, and reduced quality of life particularly due to symptoms such as pain, fatigue, and morning stiffness. This manifestation is comparable to Amavata in Ayurveda. A 26-year-old female diagnosed with RA was treated with Ayurveda modalities including Valuka swedana (~sudation therapy using sand), Virechana (~therapeutic purgation), Basti (~therapeutic enema), and Samshamana snehapana (~type of internal oleation for palliative purpose). The patient was assessed both subjectively and objectively before and after completion of the treatment. Before treatment, the values of rheumatoid factor, C-reactive protein, and erythrocyte sedimentation rate were 358.4, 13.7, and 80, respectively, which were reduced to 153.1, 2.74, and 17, respectively, after one month of treatment. In addition, marked improvement in clinical signs and symptoms such as pain, stiffness, and swelling in joints was also observed. The present case report showcases the significant effect of Valuka swedana, Virechana, Yoga basti, and Snehapana in the management of Amavata.
类风湿性关节炎(RA)是一种自身免疫性系统疾病,由于疼痛、疲劳和晨僵等症状,会导致功能衰退、残疾和生活质量下降。这种表现相当于阿育吠陀中的 "Amavata"。一名 26 岁的女性被诊断出患有 RA,她接受了阿育吠陀疗法的治疗,包括 Valuka swedana(使用沙子的熏蒸疗法)、Virechana(治疗性清肠)、Basti(治疗性灌肠)和 Samshamana snehapana(用于缓和目的的内服发泡剂)。治疗前后对患者进行了主观和客观评估。治疗前,类风湿因子、C 反应蛋白和红细胞沉降率的数值分别为 358.4、13.7 和 80,治疗一个月后分别降至 153.1、2.74 和 17。此外,关节疼痛、僵硬和肿胀等临床症状和体征也明显改善。本病例报告展示了 Valuka swedana、Virechana、Yoga basti 和 Snehapana 在治疗 Amavata 方面的显著效果。
{"title":"Management of Amavata with Panchakarma treatment – A case report","authors":"Diksha Kabra, Santosh Bhatted","doi":"10.4103/jacr.jacr_69_22","DOIUrl":"https://doi.org/10.4103/jacr.jacr_69_22","url":null,"abstract":"Rheumatoid Arthritis (RA) is an autoimmune systemic disease, resulting in functional decline, disability, and reduced quality of life particularly due to symptoms such as pain, fatigue, and morning stiffness. This manifestation is comparable to Amavata in Ayurveda. A 26-year-old female diagnosed with RA was treated with Ayurveda modalities including Valuka swedana (~sudation therapy using sand), Virechana (~therapeutic purgation), Basti (~therapeutic enema), and Samshamana snehapana (~type of internal oleation for palliative purpose). The patient was assessed both subjectively and objectively before and after completion of the treatment. Before treatment, the values of rheumatoid factor, C-reactive protein, and erythrocyte sedimentation rate were 358.4, 13.7, and 80, respectively, which were reduced to 153.1, 2.74, and 17, respectively, after one month of treatment. In addition, marked improvement in clinical signs and symptoms such as pain, stiffness, and swelling in joints was also observed. The present case report showcases the significant effect of Valuka swedana, Virechana, Yoga basti, and Snehapana in the management of Amavata.","PeriodicalId":239185,"journal":{"name":"Journal of Ayurveda Case Reports","volume":"74 1","pages":"119 - 124"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139364911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of plaque psoriasis (~Ekakushta) through Ayurvedic approach: An experience 通过阿育吠陀疗法治疗斑块状银屑病(~Ekakushta):经验
Pub Date : 2023-07-01 DOI: 10.4103/jacr.jacr_94_22
Darshan M Mahulkar, V. Huddar, Reetu
Psoriasis is one of a variety of illnesses brought on by the autoimmune response and is characterized by the rapid inflammatory proliferation of sick skin cells. Even though the illness was first identified several decades ago, the etiology and therapy appear to remain understudied. In Ayurveda, many herbs have proved efficacy in the treatment of psoriasis, but the disease's complex etiology requires a multimodal therapeutic strategy. A 22-year-old male patient with persistent plaque psoriasis in the last three years presented with erythematous plaques over the back, chest, neck, legs, abdomen, scalp, and forehands. The Auspitz sign, Candle grease sign, and Koebner phenomenon were positive. The treatment plan was based on the Ayurvedic Samprapti (~pathophysiology) of Ekakushta (~plaque psoriasis). Virechana (~therapeutic purgation) along with Ayurvedic oral medicines and a wholesome dietary regimen were given. Within eight months of the treatment, the psoriatic lesions and associated signs and symptoms were healed effectively. No adverse events were reported during the course of therapy and no recurrence was noticed as of reporting the present case report. Altogether, multimodal Ayurveda treatment can be an effective and safe solution for plaque psoriasis.
牛皮癣是由自身免疫反应引起的多种疾病之一,其特点是患病皮肤细胞迅速发炎增殖。尽管这种疾病在几十年前就被首次发现,但其病因和治疗方法似乎仍未得到充分研究。在阿育吠陀中,许多草药都被证明对治疗银屑病有疗效,但这种疾病的病因复杂,需要采取多模式治疗策略。一名 22 岁的男性患者在过去三年中一直患有斑块状银屑病,背部、胸部、颈部、腿部、腹部、头皮和前手出现红斑。奥斯皮茨征、蜡烛油征和科布纳现象均呈阳性。治疗方案以 Ekakushta(~斑块型银屑病)的阿育吠陀 Samprapti(~病理生理学)为基础。除了阿育吠陀口服药物和健康的饮食方案外,还进行了 Virechana(治疗性净化)。治疗八个月后,银屑病皮损及相关症状和体征得到有效治愈。治疗过程中未出现任何不良反应,截至本病例报告发布时也未发现复发情况。总之,多模式阿育吠陀疗法可以有效、安全地治疗斑块状银屑病。
{"title":"Management of plaque psoriasis (~Ekakushta) through Ayurvedic approach: An experience","authors":"Darshan M Mahulkar, V. Huddar, Reetu","doi":"10.4103/jacr.jacr_94_22","DOIUrl":"https://doi.org/10.4103/jacr.jacr_94_22","url":null,"abstract":"Psoriasis is one of a variety of illnesses brought on by the autoimmune response and is characterized by the rapid inflammatory proliferation of sick skin cells. Even though the illness was first identified several decades ago, the etiology and therapy appear to remain understudied. In Ayurveda, many herbs have proved efficacy in the treatment of psoriasis, but the disease's complex etiology requires a multimodal therapeutic strategy. A 22-year-old male patient with persistent plaque psoriasis in the last three years presented with erythematous plaques over the back, chest, neck, legs, abdomen, scalp, and forehands. The Auspitz sign, Candle grease sign, and Koebner phenomenon were positive. The treatment plan was based on the Ayurvedic Samprapti (~pathophysiology) of Ekakushta (~plaque psoriasis). Virechana (~therapeutic purgation) along with Ayurvedic oral medicines and a wholesome dietary regimen were given. Within eight months of the treatment, the psoriatic lesions and associated signs and symptoms were healed effectively. No adverse events were reported during the course of therapy and no recurrence was noticed as of reporting the present case report. Altogether, multimodal Ayurveda treatment can be an effective and safe solution for plaque psoriasis.","PeriodicalId":239185,"journal":{"name":"Journal of Ayurveda Case Reports","volume":"1 1","pages":"137 - 142"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139365477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Ayurveda Case Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1